Expression of aberrant β-catenin and impaired p63 in craniopharyngiomas

British Journal of Neurosurgery

Volumn 24, Issue 3, 2010, Pages 264-271

  Cao, J ^a   Lin, J P ^a   Yang, L X ^a   Chen, K ^a   Huang, Z S ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Craniopharyngiomas; Ki 67; P63; catenin

Indexed keywords

BETA CATENIN; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P63;

ADOLESCENT; ADULT; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL NUCLEUS; CELL STRUCTURE; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; CRANIOPHARYNGIOMA; CYTOPLASM; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEFECT; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TUMOR CLASSIFICATION;

EID: 77952469581     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688690903576237     Document Type: Article

References (33)

1. Bunin GR, Surawicz TS, Witman PA, et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;89:(4)547-51.
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109, 238-40.
3. Hassanein AM, Glanz SM, Kessler HP, et al. Beta-catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. Am J Clin Pathol 2003;120:732-6.
4. Kato K, Nakatani Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 2004;203:814-21.
5. Hofmann BM, Kreutzer J, Saeger W, et al. Nuclear betacatenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and Rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 2006;30(12):1595-603.
6. Sekine S, Sato S, Takata T, et al. Beta-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas. Am J Pathol 2003;163(5):1707-12.
7. Hölsken A, Kreutzer J, Hofmann BM, et al. Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol 2009;19:357-64.
8. Buslei R, Nolde M, Hofmann B, et al. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005;109(6):589-97.
9. Liu X, Rubin JS, Kimmel AR. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol 2005;15:1989-97.
10. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810.
11. Wikramanayake AH, Hong M, Lee PN, et al. An ancient role for nuclear beta-catenin in the evolution of axial polarity and germ layer segregation. Nature 2003;426(6965):446-50.
12. Buslei R, Holsken A, Hofmann B, et al. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol (Berl) 2007;113(5):585-90.
13. Sarubi JC, Bei H, Adams EF, et al. Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes. Neurosci Lett 2001;310(1):5-8.
14. Nozaki M, Tada M, Matsuko R. Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumours of the central nervous system: reappraisal by yeast functional assay. Acta Neuropathol (Berl) 1998;95(3):291-6.
15. Truong AB, Khavari PA. Control of keratinocyte proliferation and differentiation by p63. Cell Cycle 2007;6(3):295-9.
16. Foschini MP, Gaiba A, Cocchi R, et al. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 2004;444(4):332-9.
17. Yang A, Kaghad M, Wang Y, et al. P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2(3):305-16.
18. Osada M, Ohba M, Kawahara C, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998;4(7):839-43.
19. Kleihues P, Cavenee WK. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press; 2000.
20. Tomkova K, El-Rifai W, Vilgelm A, et al. The gastrin gene promoter is regulated by p73 isoforms in tumor cells. Oncogene 2006;25(44):6032-6.
21. Paulus W, Honegger J, Keyvani K, Fahlbusch, Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 1999;97(4):377-82.
22. Giangaspero F, Burger PC, Osborne DR. Suprasellar papillary squamous epithelioma ("papillary craniopharyngioma"). Am J Surg Pathol 1984;8(1):57-64.
23. Tanaka Y, Kato K, Notohara K, et al. Significance of aberrant (cytoplasmic/nuclear) expression of beta-catenin in pancreatoblastoma. J Pathol 2003;199(2):185-90.
24. Ohazama A, Tucker A, Sharpe PT. Organized tooth-specific cellular differentiation stimulated by BMP4. J Dent Res 2005;84(7):603-6.
25. Nakatani Y, Masudo K, Miyagi Y, et al. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of the fetal lung type: up regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 2002;15(16):617-24.
26. Kirchner T, Brabletz T. Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol 2000;157(4):1113-21.
27. Di Como CJ, Urist MJ, Babayan I, et al. P63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8(2):494-501.
28. Yamaguchi K, Wu L, Caballero O, et al. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer 2000;86(5):684-9.
29. Hu H, Xia SH, Li AD, et al. Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 2002;102(6):580-3.
30. Park BJ, Lee SJ, Kim JI, et al. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 2000;60(13):3370-4.
31. Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000;87(3):368-372.
32. Patturajan M, Nomoto S, Sommer M, et al. DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell 2002;1(4):369-79.
33. Koga F, Kawakami S, Kumagai J, et al. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypesofurothelialneoplasms. BrJCancer 2003;88(5):740-7.